CATALYST FINANCIAL PARTNERS LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1927537 BOSTON, MA

Position in REGN

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$356,959

+$39,721 QoQ

Shares Held

462

+12.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

CATALYST FINANCIAL PARTNERS LLC holds $1,567,578 across 4 Biotechnology names. REGN ranks #2 (22.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,654	$738,577
2	REGN	Regeneron Pharmaceuticals, Inc. This page	462	$356,959
3	DMAC	DiaMedica Therapeutics Inc.	38,457	$260,353
4	ABOS	Acumen Pharmaceuticals, Inc.	89,699	$211,689

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$356,959	462	+12.4%	Shares	Sole	2026-05-12
2025-12-31	$317,238	411	+27.2%	Shares	Sole	2026-02-04
2024-12-31	$230,082	323	-1.8%	Shares	Sole	2025-01-30
2024-09-30	$345,857	329	+0.9%	Shares	Sole	2024-10-28
2024-06-30	$342,635	326	+3.8%	Shares	Sole	2024-07-25
2024-03-31	$302,221	314	+6.4%	Shares	Sole	2024-04-23
2023-12-31	$259,095	295	+3.1%	Shares	Sole	2024-02-07
2023-09-30	$235,366	286	—	Shares	Sole	2023-10-26
No filing history on record for this holder in this stock.